The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 13, 2024

Filed:

Aug. 21, 2020
Applicants:

Progenics Pharmaceuticals, Inc., N. Billerica, MA (US);

Exini Diagnostics Ab, Lund, SE;

Inventors:

Aseem Undvall Anand, Queens, NY (US);

Karl Vilhelm Sjöstrand, Atlantic Highlands, NJ (US);

Jens Filip Andreas Richter, Lund, SE;

Assignees:

Progenics Pharmaceuticals, Inc., N. Billerica, MA (US);

EXINI Diagnostics AB, Lund, SE;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G06V 10/25 (2022.01); G06T 7/00 (2017.01); G16H 30/40 (2018.01); G16H 50/20 (2018.01);
U.S. Cl.
CPC ...
G06T 7/0012 (2013.01); G06V 10/25 (2022.01); G16H 30/40 (2018.01); G16H 50/20 (2018.01); G06T 2207/10081 (2013.01);
Abstract

Presented herein are systems and methods that provide for automated analysis of medical images to determine a predicted disease status (e.g., prostate cancer status) and/or a value corresponding to predicted risk of the disease status for a subject. The approaches described herein leverage artificial intelligence (AI) to analyze intensities of voxels in a functional image, such as a PET image, and determine a risk and/or likelihood that a subject's disease, e.g., cancer, is aggressive. The approaches described herein can provide predictions of whether a subject that presents a localized disease has and/or will develop aggressive disease, such as metastatic cancer. These predictions are generated in a fully automated fashion and can be used alone, or in combination with other cancer diagnostic metrics (e.g., to corroborate predictions and assessments or highlight potential errors). As such, they represent a valuable tool in support of improved cancer diagnosis and treatment.


Find Patent Forward Citations

Loading…